What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Orphan Drug

PUBLISHER: TechNavio | PRODUCT CODE: 1748553

PUBLISHER: TechNavio | PRODUCT CODE: 1748553

Global Behcets Disease Therapeutics Market 2025-2029

PUBLISHED: June 7, 2025

PAGES: 219 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The behcets disease therapeutics market is forecasted to grow by USD 589.6 mn during 2024-2029, accelerating at a CAGR of 7.2% during the forecast period. The report on the behcets disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.7%
CAGR	7.2%
Incremental Value	$589.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's behcets disease therapeutics market is segmented as below:

By Route Of Administration

Oral
Injectable

By Product

Small molecules
Biologics

By End-user

Hospitals
Specialty clinics
Homecare
Others

By Age Group

Adult
Geriatric
Pediatric

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing awareness about rare diseases as one of the prime reasons driving the behcets disease therapeutics market growth during the next few years. Also, strategic alliances among vendors and advent of novel therapeutics will lead to sizable demand in the market.

The report on the behcets disease therapeutics market covers the following areas:

Behcets Disease Therapeutics Market sizing
Behcets Disease Therapeutics Market forecast
Behcets Disease Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading behcets disease therapeutics market vendors that include AbbVie Inc., Amgen Inc., Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Mylan, Novartis AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the behcets disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73638

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Behcets Disease Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Behcets Disease Therapeutics Market 2019 - 2023 ($ million)
5.2 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Age Group segment analysis 2019 - 2023
- Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Behcets Disease Therapeutics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Route of Administration

8.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
8.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
8.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
8.4 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

9 Market Segmentation by Product

9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
9.3 Small molecules - Market size and forecast 2024-2029
- Chart on Small molecules - Market size and forecast 2024-2029 ($ million)
- Data Table on Small molecules - Market size and forecast 2024-2029 ($ million)
- Chart on Small molecules - Year-over-year growth 2024-2029 (%)
- Data Table on Small molecules - Year-over-year growth 2024-2029 (%)
9.4 Biologics - Market size and forecast 2024-2029
- Chart on Biologics - Market size and forecast 2024-2029 ($ million)
- Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
- Chart on Biologics - Year-over-year growth 2024-2029 (%)
- Data Table on Biologics - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Specialty clinics - Market size and forecast 2024-2029
- Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
10.5 Homecare - Market size and forecast 2024-2029
- Chart on Homecare - Market size and forecast 2024-2029 ($ million)
- Data Table on Homecare - Market size and forecast 2024-2029 ($ million)
- Chart on Homecare - Year-over-year growth 2024-2029 (%)
- Data Table on Homecare - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Market Segmentation by Age Group

11.1 Market segments
- Chart on Age Group - Market share 2024-2029 (%)
- Data Table on Age Group - Market share 2024-2029 (%)
11.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
11.3 Adult - Market size and forecast 2024-2029
- Chart on Adult - Market size and forecast 2024-2029 ($ million)
- Data Table on Adult - Market size and forecast 2024-2029 ($ million)
- Chart on Adult - Year-over-year growth 2024-2029 (%)
- Data Table on Adult - Year-over-year growth 2024-2029 (%)
11.4 Geriatric - Market size and forecast 2024-2029
- Chart on Geriatric - Market size and forecast 2024-2029 ($ million)
- Data Table on Geriatric - Market size and forecast 2024-2029 ($ million)
- Chart on Geriatric - Year-over-year growth 2024-2029 (%)
- Data Table on Geriatric - Year-over-year growth 2024-2029 (%)
11.5 Pediatric - Market size and forecast 2024-2029
- Chart on Pediatric - Market size and forecast 2024-2029 ($ million)
- Data Table on Pediatric - Market size and forecast 2024-2029 ($ million)
- Chart on Pediatric - Year-over-year growth 2024-2029 (%)
- Data Table on Pediatric - Year-over-year growth 2024-2029 (%)
11.6 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)

12 Customer Landscape

12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
13.10 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.11 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
13.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
13.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.14 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
13.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
13.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints

15 Competitive Landscape

15.1 Overview
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
- Overview on factors of disruption
15.4 Industry risks
- Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
- Companies covered
16.2 Company ranking index
- Company ranking index
16.3 Market positioning of companies
- Matrix on companies position and classification
16.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
16.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
16.6 Chugai Pharmaceutical Co. Ltd.
- Chugai Pharmaceutical Co. Ltd. - Overview
- Chugai Pharmaceutical Co. Ltd. - Product / Service
- Chugai Pharmaceutical Co. Ltd. - Key news
- Chugai Pharmaceutical Co. Ltd. - Key offerings
- SWOT
16.7 Eisai Co. Ltd.
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
- SWOT
16.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
16.9 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
16.10 Mylan
- Mylan - Overview
- Mylan - Product / Service
- Mylan - Key offerings
- SWOT
16.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
16.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
16.13 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

17 Appendix

17.1 Scope of the report
17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
17.3 Currency conversion rates for US$
- Currency conversion rates for US$
17.4 Research methodology
- Research methodology
17.5 Data procurement
- Information sources
17.6 Data validation
- Data validation
17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
17.8 Data synthesis
- Data synthesis
17.9 360 degree market analysis
- 360 degree market analysis
17.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR73638

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits9: Executive Summary - Chart on Incremental Growth
Exhibits10: Executive Summary - Data Table on Incremental Growth
Exhibits11: Executive Summary - Chart on Company Market Positioning
Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits13: Overview on criticality of inputs and factors of differentiation
Exhibits14: Overview on factors of disruption
Exhibits15: Impact of drivers and challenges in 2024 and 2029
Exhibits16: Parent Market
Exhibits17: Data Table on - Parent Market
Exhibits18: Market characteristics analysis
Exhibits19: Value chain analysis
Exhibits20: Offerings of companies included in the market definition
Exhibits21: Market segments
Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits26: Historic Market Size - Data Table on Global Behcets Disease Therapeutics Market 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits33: Five forces analysis - Comparison between 2024 and 2029
Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits39: Chart on Market condition - Five forces 2024 and 2029
Exhibits40: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits41: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits42: Chart on Comparison by Route of Administration
Exhibits43: Data Table on Comparison by Route of Administration
Exhibits44: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits48: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits49: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits50: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits51: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits52: Market opportunity by Route of Administration ($ million)
Exhibits53: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits54: Chart on Product - Market share 2024-2029 (%)
Exhibits55: Data Table on Product - Market share 2024-2029 (%)
Exhibits56: Chart on Comparison by Product
Exhibits57: Data Table on Comparison by Product
Exhibits58: Chart on Small molecules - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Small molecules - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Small molecules - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Small molecules - Year-over-year growth 2024-2029 (%)
Exhibits62: Chart on Biologics - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Biologics - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Biologics - Year-over-year growth 2024-2029 (%)
Exhibits66: Market opportunity by Product ($ million)
Exhibits67: Data Table on Market opportunity by Product ($ million)
Exhibits68: Chart on End-user - Market share 2024-2029 (%)
Exhibits69: Data Table on End-user - Market share 2024-2029 (%)
Exhibits70: Chart on Comparison by End-user
Exhibits71: Data Table on Comparison by End-user
Exhibits72: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits76: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits77: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits78: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits79: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits80: Chart on Homecare - Market size and forecast 2024-2029 ($ million)
Exhibits81: Data Table on Homecare - Market size and forecast 2024-2029 ($ million)
Exhibits82: Chart on Homecare - Year-over-year growth 2024-2029 (%)
Exhibits83: Data Table on Homecare - Year-over-year growth 2024-2029 (%)
Exhibits84: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits85: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits86: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits87: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits88: Market opportunity by End-user ($ million)
Exhibits89: Data Table on Market opportunity by End-user ($ million)
Exhibits90: Chart on Age Group - Market share 2024-2029 (%)
Exhibits91: Data Table on Age Group - Market share 2024-2029 (%)
Exhibits92: Chart on Comparison by Age Group
Exhibits93: Data Table on Comparison by Age Group
Exhibits94: Chart on Adult - Market size and forecast 2024-2029 ($ million)
Exhibits95: Data Table on Adult - Market size and forecast 2024-2029 ($ million)
Exhibits96: Chart on Adult - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Adult - Year-over-year growth 2024-2029 (%)
Exhibits98: Chart on Geriatric - Market size and forecast 2024-2029 ($ million)
Exhibits99: Data Table on Geriatric - Market size and forecast 2024-2029 ($ million)
Exhibits100: Chart on Geriatric - Year-over-year growth 2024-2029 (%)
Exhibits101: Data Table on Geriatric - Year-over-year growth 2024-2029 (%)
Exhibits102: Chart on Pediatric - Market size and forecast 2024-2029 ($ million)
Exhibits103: Data Table on Pediatric - Market size and forecast 2024-2029 ($ million)
Exhibits104: Chart on Pediatric - Year-over-year growth 2024-2029 (%)
Exhibits105: Data Table on Pediatric - Year-over-year growth 2024-2029 (%)
Exhibits106: Market opportunity by Age Group ($ million)
Exhibits107: Data Table on Market opportunity by Age Group ($ million)
Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits109: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits110: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits111: Chart on Geographic comparison
Exhibits112: Data Table on Geographic comparison
Exhibits113: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits158: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits159: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits161: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits162: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits163: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits164: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits165: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits166: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits167: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits168: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits169: Market opportunity By Geographical Landscape ($ million)
Exhibits170: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits171: Impact of drivers and challenges in 2024 and 2029
Exhibits172: Overview on criticality of inputs and factors of differentiation
Exhibits173: Overview on factors of disruption
Exhibits174: Impact of key risks on business
Exhibits175: Companies covered
Exhibits176: Company ranking index
Exhibits177: Matrix on companies position and classification
Exhibits178: AbbVie Inc. - Overview
Exhibits179: AbbVie Inc. - Product / Service
Exhibits180: AbbVie Inc. - Key news
Exhibits181: AbbVie Inc. - Key offerings
Exhibits182: SWOT
Exhibits183: Amgen Inc. - Overview
Exhibits184: Amgen Inc. - Product / Service
Exhibits185: Amgen Inc. - Key news
Exhibits186: Amgen Inc. - Key offerings
Exhibits187: SWOT
Exhibits188: Chugai Pharmaceutical Co. Ltd. - Overview
Exhibits189: Chugai Pharmaceutical Co. Ltd. - Product / Service
Exhibits190: Chugai Pharmaceutical Co. Ltd. - Key news
Exhibits191: Chugai Pharmaceutical Co. Ltd. - Key offerings
Exhibits192: SWOT
Exhibits193: Eisai Co. Ltd. - Overview
Exhibits194: Eisai Co. Ltd. - Business segments
Exhibits195: Eisai Co. Ltd. - Key offerings
Exhibits196: Eisai Co. Ltd. - Segment focus
Exhibits197: SWOT
Exhibits198: F. Hoffmann La Roche Ltd. - Overview
Exhibits199: F. Hoffmann La Roche Ltd. - Business segments
Exhibits200: F. Hoffmann La Roche Ltd. - Key news
Exhibits201: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits202: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits203: SWOT
Exhibits204: Johnson and Johnson Services Inc. - Overview
Exhibits205: Johnson and Johnson Services Inc. - Business segments
Exhibits206: Johnson and Johnson Services Inc. - Key news
Exhibits207: Johnson and Johnson Services Inc. - Key offerings
Exhibits208: Johnson and Johnson Services Inc. - Segment focus
Exhibits209: SWOT
Exhibits210: Mylan - Overview
Exhibits211: Mylan - Product / Service
Exhibits212: Mylan - Key offerings
Exhibits213: SWOT
Exhibits214: Novartis AG - Overview
Exhibits215: Novartis AG - Business segments
Exhibits216: Novartis AG - Key news
Exhibits217: Novartis AG - Key offerings
Exhibits218: Novartis AG - Segment focus
Exhibits219: SWOT
Exhibits220: Pfizer Inc. - Overview
Exhibits221: Pfizer Inc. - Product / Service
Exhibits222: Pfizer Inc. - Key news
Exhibits223: Pfizer Inc. - Key offerings
Exhibits224: SWOT
Exhibits225: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits226: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits227: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits228: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits229: SWOT
Exhibits230: Inclusions checklist
Exhibits231: Exclusions checklist
Exhibits232: Currency conversion rates for US$
Exhibits233: Research methodology
Exhibits234: Information sources
Exhibits235: Data validation
Exhibits236: Validation techniques employed for market sizing
Exhibits237: Data synthesis
Exhibits238: 360 degree market analysis
Exhibits239: List of abbreviations